表紙
市場調查報告書
商品編碼
1035430

Charcot-Marie-Tooth 病的全球市場:疾病類型、藥物類型、分銷渠道、區域規模、份額、展望、機會分析(2021-2028)

Charcot-Marie-Tooth Disease Market, by Disease Type, by Drug Type, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 189 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

Charcot-Marie-Tooth (CMT) 病是由影響控制運動和感覺的周圍神經的結構和功能的基因突變引起的。基因缺陷使周圍神經的神經纖維(軸突)和髓鞘(分離神經纖維的脂肪層)退化。這削弱了大腦和四肢之間神經信號的傳遞,導致肌肉萎縮和感覺下降。隨著 Charcot-Marie-Tooth 病的進展,症狀從腳和腿蔓延到手和手臂。

症狀的嚴重程度(腿、腳踝、足部無力、足部肌肉量減少、足弓高度、腳趾甲內生(錘狀趾)、行走/跑步能力下降等)包括家庭成員. 因人而異。 CMT 的各種類型和亞型是根據突變基因、基因型、神經傳導速度、發病年齡、疾病嚴重程度、臨床症狀和周圍神經損傷確定的。

本報告調查和分析了全球 Charcot-Marie-Tooth 病市場,以及按促進因素、抑制因素、COVID-19 影響、疾病類型、藥物類型、分銷渠道和地區劃分的市場信息。提供了企業概況。

目錄

第 1 章調查目標/先決條件

第二章市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
    • 市場概況:按疾病類型
    • 市場概況:按藥物類型
    • 市場概況:按分銷渠道
    • 市場概況:按地區
    • 市場機會圖

第 3 章 Charcot-Marie-Tooth 病的全球市場洞察

  • 促進因素
  • 抑製器
  • 市場機會
  • 影響分析
  • 管道分析
  • 市場趨勢
  • 產品發佈
  • 主要開發
  • 監管場景
  • 合作與收購
  • 流行病學
  • PEST 分析

第 4 章 Charcot-Marie-Tooth 病的全球市場-COVID-19 影響分析

  • 經濟影響
  • COVID-19 流行病學
  • COVID-19 對需求和供應鏈的影響

第 5 章 Charcot-Marie-Tooth 病全球市場:按疾病類型(2017-2028 年(100 萬美元))

  • 簡介
  • CMT 1
  • CMT 2
  • CMT 3
  • 其他

第 6 章 Charcot-Marie-Tooth 病全球市場:按藥物類型(2017-2028(100 萬美元))

  • 簡介
  • 非甾體抗炎藥
  • Cyclooxygenase-2 抑製劑
  • 三環類抗抑鬱藥
  • 抗驚厥藥
  • 鎮痛藥
  • 管道醫學

第 7 章 Charcot-Marie-Tooth 病全球市場:按分銷渠道(2017-2028 年(100 萬美元)

  • 簡介
  • 醫院藥房
  • 零售藥店
  • 網上藥店

第 8 章 Charcot-Marie-Tooth 病全球市場:按地區(2017-2028 年(100 萬美元))

  • 簡介
  • 北美
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章競技快照

企業簡介

    • Addex Therapeutics Ltd.
    • Affectis Pharmaceuticals AG
    • Genzyme Corp
    • Lead Discovery Center GmbH
    • Pharnext SA
    • Acceleron Pharma
    • MedDay Pharmaceuticals
    • Bristol-Myers-Squibb Company
    • Inflectis Bio Science Health Company
    • Helixmith Co., Ltd.
    • Neurogene Inc.

第10章 章節

目錄
Product Code: CMI4698

Charcot-marie-tooth (CMT) disease is caused by mutations in the genes that affect the structure and function of peripheral nerves that control movement and sensation. Defective genes can cause the nerve fibers (axons) or myelin sheaths (the fat layer that separates nerve fibers) to degenerate in the peripheral nerves. This weakens the transmission of nerve signals between the brain and limbs, causing muscle atrophy and decreased sensation. As charcot-marie-tooth disease progresses, symptoms will spread from the feet and legs to the hands and arms.

The severity of symptoms (that includes weakness in the legs, ankles, and feet, decreased muscle mass in the legs and feet, high foot arches, curled toes (hammer toes), and decreased walking and running ability, among others) varies from person to person, including between family members. The different types and subtypes of CMT are determined based on the mutant gene, genetic type, nerve conduction velocity, age of onset, disease severity, clinical symptoms, and peripheral nerve injury. The different types of CMT diseases include CMT1, CMT2, CMT3, CMT4, CMTX, and DICMT.

Market Dynamics

Increasing prevalence of charcot-marie tooth disease is one major factor driving the market growth. For instance, according to a data published by the Medscape in January 2021, the prevalence of CMT disease is one in 2,500 population, which is approximately 125,000 people in the U.S. The incidence of CMT 1 is 15 per 100,000 population; the incidence of CMT 1A is 10.5 per 100,000 population, or 70% of CMT 1. The incidence of CMT 2 is seven per 100,000 people. CMT X patients account for at least 10-20% of CMT syndrome patients.

Key features of the study:

  • This report provides in-depth analysis of the global charcot-marie-tooth disease market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global charcot-marie-tooth disease market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include Addex Therapeutics Ltd., Affectis Pharmaceuticals AG, Genzyme Corp, Lead Discovery Center GmbH, Pharnext SA, Acceleron Pharma, MedDay Pharmaceuticals, Bristol-Myers-Squibb Company, Inflectis Bio Science Health Company, Helixmith Co., Ltd., and Neurogene Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global charcot-marie-tooth disease market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global charcot-marie-tooth disease market

Detailed Segmentation:

  • Global Charcot-Marie-Tooth Disease Market, By Disease Type:
    • CMT 1
    • CMT 2
    • CMT 3
    • Others
  • Global Charcot-Marie-Tooth Disease Market, By Drug Type:
    • Nonsteroidal anti-inflammatory drugs
    • Cyclooxygenase-2 inhibitors
    • Tricyclic antidepressants
    • Anticonvulsants
    • Analgesics
    • Pipeline Drug
  • Global Charcot-Marie-Tooth Disease Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Charcot-Marie-Tooth Disease Market, By Region:
    • North America
      • By Disease Type
      • CMT 1
      • CMT 2
      • CMT 3
      • Others
      • By Drug Type
      • Nonsteroidal anti-inflammatory drugs
      • Cyclooxygenase-2 inhibitors
      • Tricyclic antidepressants
      • Anticonvulsants
      • Analgesics
      • Pipeline Drug
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • U.S.
      • Canada
    • Latin America
      • By Disease Type
      • CMT 1
      • CMT 2
      • CMT 3
      • Others
      • By Drug Type
      • Nonsteroidal anti-inflammatory drugs
      • Cyclooxygenase-2 inhibitors
      • Tricyclic antidepressants
      • Anticonvulsants
      • Analgesics
      • Pipeline Drug
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Europe
      • By Disease Type
      • CMT 1
      • CMT 2
      • CMT 3
      • Others
      • By Drug Type
      • Nonsteroidal anti-inflammatory drugs
      • Cyclooxygenase-2 inhibitors
      • Tricyclic antidepressants
      • Anticonvulsants
      • Analgesics
      • Pipeline Drug
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Russia
      • Rest of Europe
    • Asia Pacific
      • By Disease Type
      • CMT 1
      • CMT 2
      • CMT 3
      • Others
      • By Drug Type
      • Nonsteroidal anti-inflammatory drugs
      • Cyclooxygenase-2 inhibitors
      • Tricyclic antidepressants
      • Anticonvulsants
      • Analgesics
      • Pipeline Drug
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
    • Middle East
      • By Disease Type
      • CMT 1
      • CMT 2
      • CMT 3
      • Others
      • By Drug Type
      • Nonsteroidal anti-inflammatory drugs
      • Cyclooxygenase-2 inhibitors
      • Tricyclic antidepressants
      • Anticonvulsants
      • Analgesics
      • Pipeline Drug
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Country
      • GCC
      • Israel
      • Rest of Middle East
    • Africa
      • By Disease Type
      • CMT 1
      • CMT 2
      • CMT 3
      • Others
      • By Drug Type
      • Nonsteroidal anti-inflammatory drugs
      • Cyclooxygenase-2 inhibitors
      • Tricyclic antidepressants
      • Anticonvulsants
      • Analgesics
      • Pipeline Drug
      • By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
      • By Region/Country
      • South Africa
      • Central Africa
      • North Africa
  • Company Profiles
    • Addex Therapeutics Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Affectis Pharmaceuticals AG
    • Genzyme Corp
    • Lead Discovery Center GmbH
    • Pharnext SA
    • Acceleron Pharma
    • MedDay Pharmaceuticals
    • Bristol-Myers-Squibb Company
    • Inflectis Bio Science Health Company
    • Helixmith Co., Ltd.
    • Neurogene Inc.

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Disease Type
    • Market Snapshot, By Drug Type
    • Market Snapshot, By Distribution Channel
    • Market Snapshot, By Region
    • Market Opportunity Map

3. Global Charcot-Marie-Tooth Disease Market Insights

  • Drivers
  • Restraints
  • Opportunity
  • Impact Analysis
  • Pipeline Analysis
  • Market Trends
  • Product Launches
  • Key Developments
  • Regulatory Scenario
  • Collaborations & Acquisitions
  • Epidemiology
  • PEST Analysis

4. Global Charcot-Marie-Tooth Disease Market- COVID-19 Impact Analysis

  • Economic Impact
  • COVID-19 Epidemiology
  • Impact of COVID-19 on demand and supply chain

5. Global Charcot-Marie-Tooth Disease Market, By Disease Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • CMT 1
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • CMT 2
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • CMT 3
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

6. Global Charcot-Marie-Tooth Disease Market, By Drug Type, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Nonsteroidal anti-inflammatory drugs
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Cyclooxygenase-2 inhibitors
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Tricyclic antidepressants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Anticonvulsants
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Analgesics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Pipeline Drug
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

7. Global Charcot-Marie-Tooth Disease Market, By Distribution Channel, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028 (US$ Million)

8. Global Charcot-Marie-Tooth Disease Market, By Region, 2017 - 2028 (US$ Million)

  • Introduction
    • Market Share Analysis, 2021 and 2028 (%)
    • Y-o-Y Growth Analysis, 2018 - 2028
    • Region at Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country, 2017-2028, (US$ Million)
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 - 2028, (US$ Mn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017-2028, (US$ Mn)
    • Market Size and Forecast By Value, and Y-o-Y Growth, By Country/Region, 2017-2028, (US$ Million)
    • South Africa
    • Central Africa
    • North Africa

9. Competitive Snapshot

Company Profiles

    • Addex Therapeutics Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Affectis Pharmaceuticals AG
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Genzyme Corp
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Lead Discovery Center GmbH
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Pharnext SA
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Acceleron Pharma
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • MedDay Pharmaceuticals
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Bristol-Myers-Squibb Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Inflectis Bio Science Health Company
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Helixmith Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
    • Neurogene Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies

10. Section

  • Research Methodology
  • About us